[Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology...

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Practice Guidelines

Background:

• The 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines introduced a paradigm shift.
• These guidelines moved from a low-density lipoprotein cholesterol (LDL-C) treat-to-target strategy to a risk reduction approach for statin therapy.
• This review compares the 2013 ACC/AHA guidelines with current European guidelines on cardiovascular prevention and dyslipidemia management.

Purpose of the Study:

• To review and compare the 2013 ACC/AHA cholesterol guidelines with European guidelines.
• To assess the impact of the ACC/AHA guidelines on clinical practice, particularly in Spain.
• To evaluate the appropriateness of the ACC/AHA guidelines for primary prevention in the Spanish population.

Main Methods:

• Comparative analysis of the 2013 ACC/AHA cholesterol guidelines and current European guidelines.
• Review of the shift from LDL-C treat-to-target to risk reduction strategies.
• Assessment of the implications for statin therapy in primary and secondary cardiovascular prevention.

Main Results:

• Both guidelines recommend similar strategies (high-dose potent statins) for patients with established cardiovascular disease.
• The ACC/AHA guidelines, if applied in primary prevention, would significantly increase the number of individuals, especially older adults, receiving statin therapy.
• The elimination of the LDL-C treat-to-target strategy may lead to confusion, decreased adherence, and potential overtreatment in primary prevention.

Conclusions:

• The European guidelines are considered more appropriate for the Spanish setting, utilizing native population risk charts.
• The European guidelines help avoid potential overtreatment with statins in primary prevention.
• This article reaffirms the recommendations of the European guidelines due to concerns regarding the ACC/AHA guidelines' impact on clinical practice and patient adherence.